Symbols

ASXC(Delisted)

Asensus Surgical·AMEX

--(--)

Signals Analysis

Bullish signal 1

Bearish signal 1

EPS Beats Expectation

Revenue Below Expectations

Key Stats

0.0000DAY`S RANGE0.0000

0.000052 WK RANGE0.0000

Open

0.0000

Prev.Close

0.0000

%Range

Turnover

Avg Vol(4W)

Market Cap

Div.Yield

P/E(TTM)

EPS(TTM)

Beta

Free Float

Shares Outstanding

%Turnover

P/E(DYN)

P/B

BVPS

High

0.0000

Low

0.0000

52 Week High

0.0000

52 Week Low

0.0000

About ASXC

Asensus Surgical, Inc.

A medical device company that develops senhance surgical systems used in minimally invasive surgeries through Digital Laparoscopy

Industry

Established Date

08/19/1988

Listing Date

04/02/2014

Exchange

American Stock Exchange

Full-time Employees

207

Fiscal Year Ends

12-31

Website

www.asensus.com

Security Type

Common stock

Office address

TW Alexander Drive, Suite 160, Durham, NC 27703

Business

Introduction

Asensitivity Surgical, Inc., originally established as an NCS joint venture on August 19, 1988, is a medical device company specializing in the development and sale of robot-assisted surgical systems. Asensitivity Surgical, Inc., is digitizing the interface between surgeons and patients to usher in a new era of performance-directed surgery by unlocking clinical intelligence, consistently delivering superior therapeutic outcomes and new surgical standards. This builds on digital laparoscopic technology, a system that enhances the surgeon's control and reduces surgical variability. By adding machine vision, enhanced intelligence and deep learning capabilities throughout the surgical process, the company intends to address the clinical, cognitive and economic deficiencies that currently drive surgical outcomes and value-based healthcare as a whole.

Company Financials

EPS

ASXC has released its 2024 Q2 earnings. EPS was reported at -0.07, versus the expected -0.06, missing expectations. The chart below visualizes how ASXC has performed over recent quarters, highlighting trends in earnings surprises.

Revenue & Expenses

ASXC has released its 2024 Q2 earnings report, with revenue of 2.21M, reflecting a YoY change of 104.16%, and net profit of -25.75M, showing a YoY change of -24.62%. The Sankey diagram below clearly presents ASXC's revenue sources and cost distribution.